GO:0030008 TRAPP complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030008 (TRAPP complex) describes a large, multi-subunit tethering complex that mediates vesicle transport from the endoplasmic reticulum through the Golgi to the plasma membrane.
• TRAPP complexes act as guanine nucleotide exchange factors (GEFs) for Ypt/Rab GTPases, with the core complex exchanging nucleotides on Ypt1 and Ypt31/32.
• Distinct TRAPP complexes (TRAPP I, II, III) share a core set of subunits but differ in specific subunits that determine their cellular localization and function.
• TRAPP II assembly requires either Trs33 or Trs65, and loss of both subunits is lethal in yeast, highlighting their essential role in complex integrity.
• Mutations in TRAPP subunits, such as TRAPPC6B, cause neurodevelopmental disorders with trafficking disruptions, linking the complex to human disease.
• The TRAPP complex is also implicated in secretion arrest during stress granule assembly, connecting it to cellular stress responses.
Description
The TRAPP complex (transport protein particle) is a conserved multi-subunit tethering factor that orchestrates vesicle trafficking within the early secretory pathway. It functions primarily at the Golgi apparatus, where it facilitates the tethering of vesicles derived from the endoplasmic reticulum (ER) to target membranes, ensuring efficient transport through the secretory pathway. The complex was initially identified in yeast and has since been shown to be essential for ER-to-Golgi and intra-Golgi transport, as well as for autophagy. Beyond its role in membrane trafficking, the TRAPP complex serves as a guanine nucleotide exchange factor (GEF) for Ypt/Rab GTPases, activating these small GTPases to regulate vesicle docking and fusion. This dual function—tethering and GEF activity—positions TRAPP as a central regulator of secretory flux. Researchers study the TRAPP complex to understand fundamental mechanisms of intracellular transport, organelle homeostasis, and how defects in these processes contribute to human diseases such as neurodevelopmental disorders and cancer.
TRAPP complex At A Glance
| GO ID | GO:0030008 |
|---|---|
| GO term | TRAPP complex |
| Ontology | cellular_component |
| Synonym | transport protein particle, transport protein particle complex, TRAPP1, TRAPP2 |
| Major function | Tethering factor for vesicles trafficking from ER through Golgi to plasma membrane; acts as GEF for Ypt/Rab GTPases |
| Core subunits | Bet3, Bet5, Trs20, Trs23, Trs31, Trs33 (shared core) |
| Specific subunits | TRAPP II: Trs65, Trs120, Trs130; TRAPP III: Trs85 |
| Cellular localization | Golgi apparatus, with distinct pools at early and late Golgi |
| Associated GTPases | Ypt1, Ypt31/32 in yeast; Rab1, Rab11 in mammals |
What Is GO:0030008?
GO:0030008 defines the TRAPP complex as a large protein assembly that acts as a tethering factor involved in transporting vesicles from the ER through the Golgi to the plasma membrane. A TRAPP complex has a core set of proteins that are joined by specific subunits depending on the cellular component where a given TRAPP complex is active. This definition captures both the structural modularity and the functional role of the complex in vesicle trafficking.
Why Is TRAPP complex Important in Cell Biology?
The TRAPP complex is essential for the fidelity of the secretory pathway, which impacts a vast array of cellular processes including protein secretion, membrane remodeling, and autophagy. Its role as a GEF for Rab GTPases places it at the heart of vesicle trafficking regulation, influencing cell growth, polarity, and stress responses. Dysregulation of TRAPP subunits has been linked to human diseases, particularly neurodevelopmental disorders and potential roles in cancer, making it a target for both basic research and therapeutic exploration.
• TRAPP complex is a master regulator of ER-to-Golgi and intra-Golgi vesicle transport, affecting secretion of proteins and lipids.
• It serves as a GEF for Ypt1 and Ypt31/32, activating Rab GTPases that control vesicle docking and fusion.
• Mutations in TRAPP subunits cause neurodevelopmental disorders, such as those associated with TRAPPC6B variants.
• The complex is involved in autophagy, linking membrane trafficking to cellular degradation pathways.
• TRAPP II assembly requires Trs33 or Trs65, and their loss disrupts complex integrity and cell viability.
• Stress granule assembly can induce secretion arrest through TRAPP complex-mediated mechanisms.
• TRAPP subunits are conserved from yeast to humans, enabling the use of model organisms for functional studies.
• The complex is a potential therapeutic target for diseases involving secretory pathway defects.
• TRAPP complex dysfunction may contribute to cancer progression through altered secretion of growth factors and matrix proteins.
• Understanding TRAPP complex regulation provides insights into organelle homeostasis and cellular stress responses.
What Happens During TRAPP complex?
Vesicle Tethering at the Golgi
In simple terms: The TRAPP complex acts like a molecular bridge that catches vesicles arriving at the Golgi, ensuring they dock at the right spot.
The primary function of the TRAPP complex is to tether vesicles derived from the ER to the Golgi membrane. This tethering is the first step in a series of events that lead to vesicle fusion. The complex physically connects the vesicle to the target membrane, increasing the efficiency and specificity of transport. Different TRAPP complexes (I, II, III) localize to distinct Golgi subcompartments and mediate specific trafficking steps, such as ER-to-Golgi or intra-Golgi transport.
GEF Activity for Ypt/Rab GTPases
In simple terms: TRAPP complex also acts as an activator, switching on small molecular motors called Rab GTPases by exchanging their GDP for GTP.
Beyond tethering, the TRAPP complex functions as a guanine nucleotide exchange factor (GEF) for Ypt1 and Ypt31/32 in yeast, and their mammalian orthologs Rab1 and Rab11. This GEF activity is crucial for activating these GTPases, which then recruit downstream effectors to promote vesicle docking and fusion. The core subunits Bet3, Bet5, Trs23, and Trs31 form the catalytic site for nucleotide exchange.
Assembly of TRAPP Complexes
In simple terms: Different versions of the TRAPP complex are built by mixing a common set of proteins with specific additional subunits.
TRAPP complexes share a core of six subunits (Bet3, Bet5, Trs20, Trs23, Trs31, Trs33) but incorporate specific subunits to form TRAPP II (Trs65, Trs120, Trs130) or TRAPP III (Trs85). Assembly of TRAPP II requires either Trs33 or Trs65; in their absence, the complex fails to form properly, leading to trafficking defects. This modular assembly allows the complex to adapt to different cellular locations and functions.
Role in Autophagy and Stress Responses
In simple terms: TRAPP complex is also involved in cellular cleanup and stress responses, helping cells survive under adverse conditions.
TRAPP III, which contains Trs85, is specifically required for autophagy, a process that degrades damaged organelles and proteins. Additionally, stress granule assembly can induce a secretion arrest that depends on the TRAPP complex, linking membrane trafficking to stress adaptation. This suggests that TRAPP complexes integrate trafficking with cellular stress signaling pathways.
Key Genes Involved in GO:0030008 TRAPP complex
The following genes encode subunits of the TRAPP complex and its associated regulatory proteins, each with distinct roles in complex assembly, function, and disease relevance.
| Gene | Major Role | Research Relevance |
|---|---|---|
| BET3 (TRAPPC3) | Core subunit; essential for GEF activity and complex stability | Mutations linked to neurodevelopmental disorders; target for structural studies |
| BET5 (TRAPPC1) | Core subunit; part of catalytic core | Required for ER-to-Golgi transport; knockout causes trafficking defects |
| TRS20 (TRAPPC2) | Core subunit; involved in TRAPP II assembly | Mutations cause spondyloepiphyseal dysplasia tarda; model for skeletal disorders |
| TRS23 (TRAPPC4) | Core subunit; essential for GEF activity | Knockout is lethal in yeast; studied for Rab activation |
| TRS31 (TRAPPC5) | Core subunit; stabilizes complex | Involved in Golgi homeostasis; potential cancer relevance |
| TRS33 (TRAPPC6A) | Core subunit; redundant with Trs65 in TRAPP II assembly | Deletion affects TRAPP II integrity; studied in yeast models |
| TRS65 (TRAPPC13) | TRAPP II-specific subunit; required for assembly when Trs33 absent | Essential for TRAPP II function; synthetic lethal with Trs33 |
| TRS85 (TRAPPC8) | TRAPP III-specific subunit; mediates autophagy | Knockout impairs autophagy; linked to neurodegeneration |
| TRS120 (TRAPPC9) | TRAPP II-specific subunit; involved in intra-Golgi transport | Mutations associated with intellectual disability |
| TRS130 (TRAPPC10) | TRAPP II-specific subunit; regulates Golgi trafficking | Studied for role in secretion and cell polarity |
| TRAPPC6B | TRAPP II subunit; involved in complex stability | Biallelic variants cause neurodevelopmental disorder with trafficking disruptions |
| TRAPPC11 | TRAPP III subunit; linked to autophagy and Golgi integrity | Mutations cause muscular dystrophy and intellectual disability |
| TRAPPC12 | TRAPP II subunit; involved in Golgi organization | Associated with microcephaly and neurodevelopmental defects |
| YPT1 (RAB1) | Rab GTPase activated by TRAPP; regulates ER-to-Golgi transport | Key substrate for GEF activity; knockout blocks secretion |
| YPT31/32 (RAB11) | Rab GTPases activated by TRAPP; regulate intra-Golgi transport | Essential for Golgi function; studied in yeast models |
| RAB1A | Mammalian ortholog of Ypt1; regulates ER-to-Golgi | Target for cancer and viral infection studies |
| RAB11A | Mammalian ortholog of Ypt31/32; regulates recycling endosomes | Involved in cell migration and cancer metastasis |
| USO1 (p115) | Tethering factor cooperating with TRAPP | Studied for vesicle docking at Golgi |
How Is TRAPP complex Regulated?
The TRAPP complex is regulated at multiple levels, including subunit expression, post-translational modifications, and interaction with regulatory proteins. Its GEF activity is modulated by the availability of Ypt/Rab GTPases and their nucleotide state. Stress conditions, such as those inducing stress granule assembly, can lead to secretion arrest through TRAPP complex-dependent mechanisms. Additionally, the assembly of TRAPP II is regulated by the relative levels of Trs33 and Trs65, which compete for incorporation into the complex. Phosphorylation of TRAPP subunits may also influence complex localization and function, although specific kinases remain to be fully defined.
TRAPP complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TRAPPC6B | Neurodevelopmental disorder with TRAPP II and trafficking disruptions | Knockout and point-mutation knock-in in human iPSC-derived neurons |
| TRAPPC9 | Intellectual disability, microcephaly | CRISPR knockout in mouse models and patient fibroblasts |
| TRAPPC11 | Muscular dystrophy with intellectual disability | Knockout in zebrafish and human myoblasts |
| TRAPPC12 | Microcephaly and neurodevelopmental defects | Knock-in of patient variants in cell lines |
| RAB1A | Cancer progression and viral infection | Overexpression and knockout in cancer cell lines |
Neurodevelopmental Disorders
Mutations in TRAPP subunits, particularly TRAPPC6B, TRAPPC9, and TRAPPC12, have been linked to neurodevelopmental disorders characterized by intellectual disability, microcephaly, and delayed development. These mutations disrupt TRAPP II complex assembly and function, leading to impaired vesicle trafficking in neurons, which are highly dependent on efficient secretory pathways for synaptic function and growth. The identification of these variants underscores the importance of TRAPP complex in brain development and function.
Muscular Dystrophy and Autophagy Defects
Mutations in TRAPPC11, a TRAPP III subunit, cause a form of muscular dystrophy with intellectual disability and seizures. TRAPPC11 is required for autophagy, and its loss leads to impaired autophagosome formation and accumulation of damaged organelles in muscle cells. This highlights the role of TRAPP complex in maintaining muscle homeostasis through autophagy regulation.
Cancer and Secretory Pathway Dysregulation
Altered expression of TRAPP subunits has been observed in various cancers, where changes in secretion can promote tumor growth and metastasis. For example, TRAPPC6B has been implicated in cancer cell proliferation and migration, although the exact mechanisms remain under investigation. The TRAPP complex may influence cancer through its role in secreting growth factors, cytokines, and extracellular matrix components.
From TRAPP complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of TRAPP core subunit block ER-to-Golgi transport? | CRISPR knockout of BET3 or BET5 in HeLa cells followed by trafficking assays |
| How do TRAPPC6B patient mutations affect complex assembly? | Point-mutation knock-in of patient variants in iPSCs |
| Can TRAPP II-specific subunit Trs65 compensate for Trs33 loss? | Double knockout of TRS33 and TRS65 in yeast |
| What is the role of TRAPP III in autophagy? | Knockout of TRS85 in mammalian cells and autophagy flux assays |
| Does overexpression of TRAPPC9 rescue trafficking defects? | Overexpression of wild-type TRAPPC9 in patient fibroblasts |
| How does stress granule assembly affect TRAPP complex localization? | Tagged knock-in of TRAPP subunits with fluorescent proteins and live imaging |
How to Study the TRAPP complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescence microscopy | Localization and dynamics of TRAPP subunits | Visualizing Golgi tethering and vesicle transport |
| GEF activity assay | Nucleotide exchange rate on Ypt/Rab GTPases | Quantifying TRAPP catalytic activity |
| AP-MS | Protein-protein interactions and complex composition | Identifying TRAPP subunits and interactors |
| CRISPR knockout | Loss-of-function phenotypes | Assessing requirement for trafficking and autophagy |
| RNAi knockdown | Partial loss of gene function | Studying essential genes in cell lines |
| Live-cell imaging | Real-time vesicle movement | Tracking ER-to-Golgi transport |
| Autophagy flux assay | Autophagosome formation and degradation | Evaluating TRAPP III function |
| Yeast genetics | Synthetic lethality and suppressor screens | Dissecting TRAPP II assembly |
Fluorescence Microscopy and Live Imaging
Fluorescence microscopy, including confocal and live-cell imaging, is used to visualize TRAPP complex localization and vesicle trafficking in real time. Tagging TRAPP subunits with fluorescent proteins (e.g., GFP, mCherry) allows tracking of complex dynamics at the Golgi and on vesicles. Co-localization with organelle markers (e.g., ER, Golgi) confirms specific trafficking steps.
Biochemical Assays for GEF Activity
Guanine nucleotide exchange factor (GEF) activity of TRAPP is measured using in vitro nucleotide exchange assays with recombinant Ypt/Rab GTPases and fluorescent GDP analogs. These assays quantify the rate of GDP release and GTP loading, providing kinetic parameters for TRAPP-mediated activation.
Proteomics and Interaction Studies
Affinity purification coupled with mass spectrometry (AP-MS) identifies TRAPP complex subunits and interacting proteins. This approach has revealed the subunit composition of TRAPP I, II, and III and their binding partners. Proximity labeling (BioID) can capture transient interactions in living cells.
Genetic Knockout and Knockdown
CRISPR/Cas9-mediated knockout or RNAi knockdown of TRAPP subunits in cell lines and model organisms is used to assess loss-of-function phenotypes, such as secretion defects, Golgi fragmentation, and autophagy impairment. These models help establish causality between TRAPP complex components and cellular functions.
How CRISPR Can Be Used to Study GO:0030008 TRAPP complex
Knockout
CRISPR knockout of TRAPP core subunits (e.g., BET3, BET5) in cell lines results in severe secretion defects and Golgi disorganization, often leading to cell lethality. Conditional knockout in mice or yeast allows study of tissue-specific functions and synthetic lethal interactions. These models are essential for defining the essentiality of each subunit.
Point Mutation
Point mutations identified in patients (e.g., TRAPPC6B variants) can be introduced into cell lines or iPSCs using CRISPR base editing or homology-directed repair. These models help determine whether specific mutations are loss-of-function, gain-of-function, or dominant-negative, and reveal structural disruptions in the complex.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) or epitope tags (e.g., HA) at endogenous TRAPP subunit loci enables real-time imaging and biochemical purification of the complex under native regulation. This approach avoids overexpression artifacts and provides physiological insights into complex assembly and dynamics.
Overexpression
Overexpression of wild-type or mutant TRAPP subunits can rescue or exacerbate trafficking defects in patient cells. It is also used to study dominant-negative effects and to produce recombinant proteins for in vitro assays. Controlled overexpression systems (e.g., doxycycline-inducible) allow titration of expression levels.
How EDITGENE Supports TRAPP complex Research
Researchers studying TRAPP complex-related genes often need to determine whether a candidate gene is causally involved in vesicle trafficking, autophagy, or disease. EDITGENE provides comprehensive CRISPR-based services to create precise cellular models for functional validation.
Contact EDITGENE today to design your custom CRISPR model for TRAPP complex research.
Frequently Asked Questions About TRAPP complex
What is the TRAPP complex?
The TRAPP complex (GO:0030008) is a large multi-subunit tethering factor that mediates vesicle transport from the ER through the Golgi to the plasma membrane and acts as a GEF for Ypt/Rab GTPases.
What genes are involved in the TRAPP complex?
Core genes include BET3, BET5, TRS20, TRS23, TRS31, and TRS33, while specific subunits include TRS65, TRS120, TRS130 (TRAPP II) and TRS85 (TRAPP III).
What is the function of TRAPP complex in cells?
It tethers vesicles to Golgi membranes and activates Rab GTPases to promote vesicle docking and fusion, and it also participates in autophagy.
Which diseases are linked to TRAPP complex mutations?
Mutations in TRAPP subunits cause neurodevelopmental disorders, muscular dystrophy, and have been implicated in cancer.
How is TRAPP complex regulated?
Its activity is regulated by subunit availability, interaction with Ypt/Rab GTPases, and stress-induced signaling such as stress granule assembly.
What are the different types of TRAPP complexes?
TRAPP I, II, and III share a core but differ in specific subunits: TRAPP II contains Trs65, Trs120, Trs130; TRAPP III contains Trs85.
How can I study TRAPP complex using CRISPR?
CRISPR knockout, point mutation knock-in, tagged knock-in, and overexpression models can be used to dissect subunit functions and disease variants.
What methods are used to measure TRAPP GEF activity?
In vitro nucleotide exchange assays with fluorescent GDP analogs and recombinant Ypt/Rab GTPases are standard for measuring GEF activity.
Is TRAPP complex involved in autophagy?
Yes, TRAPP III, which includes Trs85, is specifically required for autophagy and autophagosome formation.
What model organisms are used to study TRAPP complex?
Yeast (Saccharomyces cerevisiae) is a key model due to conservation, and mammalian cell lines and iPSCs are used for human disease studies.
Conclusion
The TRAPP complex (GO:0030008) is a central regulator of vesicle trafficking, acting as both a tethering factor and a GEF for Rab GTPases. Its modular architecture allows specialization for distinct trafficking steps, from ER-to-Golgi transport to autophagy. Mutations in TRAPP subunits cause severe human disorders, underscoring its physiological importance. Continued research using CRISPR-based models will further elucidate its mechanisms and therapeutic potential.
References
- 1. Sacher M et al.. 2008. The TRAPP complex: insights into its architecture and function.. Traffic 9(12):2032-42 PMID: 18801063
- 2. Zappa F et al.. 2019. The TRAPP complex mediates secretion arrest induced by stress granule assembly.. EMBO J 38(19):e101704 PMID: 31429971
- 4. Almousa H et al.. 2024. TRAPPC6B biallelic variants cause a neurodevelopmental disorder with TRAPP II and trafficking disruptions.. Brain 147(1):311-324 PMID: 37713627
- 5. Kim JJ et al.. 2016. TRAPP Complexes in Secretion and Autophagy.. Front Cell Dev Biol 4:20 PMID: 27066478
- 6. Tokarev AA et al.. 2009. TRAPP II complex assembly requires Trs33 or Trs65.. Traffic 10(12):1831-44 PMID: 19843283
- 7. Lipatova Z et al.. 2019. Ypt/Rab GTPases and their TRAPP GEFs at the Golgi.. FEBS Lett 593(17):2488-2500 PMID: 31400292
- 8. Jones S et al.. 2000. The TRAPP complex is a nucleotide exchanger for Ypt1 and Ypt31/32.. Mol Biol Cell 11(12):4403-11 PMID: 11102533
